EAPC Premium Access

Alirucumab in cardiac rehabilitation patients. Clinical profile and initial results.

Topic: Pharmacology and Pharmacotherapy, Other


About the speaker

Doctor Antonio Aurelio Rojas Sanchez

Regional University Hospital Carlos Haya, Malaga (Spain)
0 follower

4 more presentations in this session

Cardiovascular pharmacology - Poster discussant:


Adverse effects of drug therapy (the first results of the study according to the outpatient register)

Speaker: Doctor Y. Lukina (Moscow, RU)


Improving adherence to medicines of secondary prevention - results of a prospective multicenter follow-up study


Statins and risk biomarkers for coronary heart disease (CHD) in type 2 diabetes mellitus patients with normal LDL cholesterol levels. 1 year prospective study in Constanta County, Romania

Speaker: Associate Professor I. Parepa (CONSTANTA, RO)


Access the full session

Poster Session 3 - Cardiovascular pharmacology

Speakers: Doctor A. Rojas Sanchez, Doctor Y. Lukina, Associate Professor I. Parepa

About the event


EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk